We are live on ! Find out more
AEON.WS

AEON Biopharma Inc
AEON.WS

Delisted

AEON.WS was delisted on the 26th of April, 2024.

Back to rankings

53 hedge funds and large institutions have $5.67M invested in AEON Biopharma Inc in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

2% more funds holding

Funds holding: 52 → 53 (+1)

18% less capital invested

Capital invested by funds: $6.9M → $5.67M (-$1.22M)

Holders
53
Holders Change
+1
Holders Change %
+1.92%
% of All Funds
0.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
3
Closed
3
Calls
$995K
Puts
–
Net Calls
+$995K
Net Calls Change
-$5K

Top Buyers

Rank Fund Capital Flow
1
PC
Periscope Capital
Ontario, Canada
+$15.2K
2
Parallax Volatility Advisers
Parallax Volatility Advisers
California
+$11.1K
3
Calamos Advisors
Calamos Advisors
Illinois
+$7.61K
4
LOAMU
Lombard Odier Asset Management (USA)
New York
+$3.8K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.55K

Top Sellers

Rank Fund Capital Flow
1
FTCM
Fir Tree Capital Management
New York
-$24K
2
AR
Advisory Research
Illinois
-$8K
3
CC
Centiva Capital
New York
-$4K
4
UOC
UBS O'Connor
Illinois
-$1.03K
5
Citadel Advisors
Citadel Advisors
Florida
-$239
Name Holding Trade Value Shares
Change 		Change in
Stake
AR
51
Advisory Research
Illinois
– -$8K -50,119 Closed
CC
52
Centiva Capital
New York
– -$4K -26,732 Closed
1 2
3

AEON.WS Hedge Fund Activity: Q3 2022 in Review

53 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in AEON Biopharma Inc (AEON.WS) for Q3 2022, worth a combined $5.67M — down 18% from $6.9M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new AEON.WS positions and 3 closed out — a net gain of 1 holder — while 4 added to existing stakes and 3 trimmed.

The largest buyer was Periscope Capital, adding an estimated $15.2K. The largest seller was Fir Tree Capital Management, exiting entirely with an estimated $24K sold.

  • 53 institutional investors held AEON Biopharma Inc (AEON.WS) as of Q3 2022, up from 52 in Q2 2022.
  • Funds reported $5.67M of AEON Biopharma Inc stock for Q3 2022, down 18% quarter-over-quarter.
  • 4 funds opened new AEON Biopharma Inc positions in Q3 2022 and 3 closed out, a net change of +1 holder.
  • The largest AEON Biopharma Inc buyer in Q3 2022 was Periscope Capital, an estimated $15.2K added.
  • The largest AEON Biopharma Inc seller in Q3 2022 was Fir Tree Capital Management, an estimated $24K sold.

Based on aggregated 13F filings for Q3 2022.